Brief Title
Effectiveness of Care in Certified Cancer Centres in Germany
Official Title
Wirksamkeit Der Versorgung in Onkologischen Zentren
Brief Summary
Assessment of the effectiveness of care in certified cancer centres for eight cancer entities
via a retrospective cohort study based on secondary data from statutory health insurance
funds and population-based clinical cancer registries.
Detailed Description
Cancer constitutes the second most frequent cause of death in Germany. To maintain a high
quality of treatment, the national cancer plan aims at a unified certification of cancer
centres.
The project "Wirksamkeit der Versorgung in onkologischen Zentren" (WiZen) investigates
effects of treatments in certified cancer centres across large populations and different
cancer entities in comparison to hospitals that do not hold a certificate.
WiZen is a retrospective comparative cohort study that analyzes incident cases of eight types
of cancer diagnosed within 2009-2017 based on nationwide health insurance data provided by
WIdO (the AOK research institute) and data from regional clinical cancer registries (CCR) for
the period 2006-2017. These eight types of cancer are colorectal cancer, pancreatic cancer,
breast cancer, gynecologic tumors, lung cancer, prostate cancer, head and neck tumors and
neuro-oncological tumors.
Study Type
Observational
Primary Outcome
Overall survival
Secondary Outcome
2-, 3-, 4-year survival
Condition
Colorectal Cancer
Intervention
Oncological certification
Study Arms / Comparison Groups
Intervention
Description: Cancer patients who have undergone substantial parts of inpatient treatment in a certified cancer centre.
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Other
Estimated Enrollment
500000
Start Date
May 1, 2017
Completion Date
June 2020
Primary Completion Date
June 2020
Eligibility Criteria
Inclusion Criteria:
- first hospitalization due to diagnosis of colorectal cancer, pancreatic cancer, breast
cancer, gynecologic tumors, lung cancer, prostate cancer, head and neck tumors, or
neuro-oncological tumors 2009-2017 [WIdO]
- hospitalization due to primary diagnosis of colorectal cancer, pancreatic cancer,
breast cancer, gynecologic tumors, lung cancer, prostate cancer, head and neck tumors,
or neuro-oncological tumors 2006-2017 [CCR]
Exclusion Criteria:
- prevalent diagnosis of colorectal cancer, pancreatic cancer, breast cancer,
gynecologic tumors, lung cancer, prostate cancer, head and neck tumors, or
neuro-oncological tumors 2006-2017
- exception: outpatient cancer diagnosis up to 12 months prior to first hospitalization
is not regarded as prevalent
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
, ,
Location Countries
Germany
Location Countries
Germany
Administrative Informations
NCT ID
NCT04334239
Organization ID
01VSF17020
Responsible Party
Principal Investigator
Study Sponsor
Technische Universität Dresden
Collaborators
Tumorzentrum Regensburg, Institut für Qualitätssicherung und Versorgungsforschung, Universität Regensburg
Study Sponsor
, ,
Verification Date
April 2020